← Leaderboards
Kathryn L Schwienteck
Virginia Commonwealth University
$72,044
Attributed
$72,044
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $36.3K · FY2017–18$50K$37.5K$25K$12.5K$0
'17
'18
Funding mix
By agency
NIH$72,044 · 1
By mechanism
F31$72,044 · 1
Top collaborators
No co-investigators on record.
Most similar at Virginia Commonwealth University
Same institution · by research overlap
- Frederick Gerard Moeller$65,095,599
- Jenny L. Wiley$18,479,501
- Aron H Lichtman$10,846,349
- Robert L Balster$5,313,015
- Richard A Glennon$4,822,005
Others in their field
Other Emerging Leaders on “Absence Of Pain Sensation”
- Jeffrey Reich · Sparian Biosciences, Inc.$21,990,518
- John Cureton Hunter · Siteone Therapeutics, Inc.$5,359,866
- Donald R Gehlert · Epiodyne, Inc.$5,302,597
- William K Schmidt · Epiodyne, Inc.$5,302,597
- James E. Barrett · Mebias Discovery, Inc.$4,805,544
- Lawrence C Kuo · Mebias Discovery, Inc.$4,805,544
Research focus
Absence Of Pain SensationAcute PainAddictionAdverse EffectsAgonistAlternative TreatmentAntibody FormationAttenuatedBaseBehavioralBehavioral StudyBuprenorphineCardiovascular SystemClinically TranslatableCompliance BehaviorConjugate VaccinesDoseDrug DevelopmentDrug DiscriminationDrug KineticsEvaluationFda ApprovedFemale6-O-Monoacetylmorphine